ArticleJournal of asthma and allergy2025

Clinical and Healthcare Cost Characteristics of Severe Asthma Patients with Long-Term Control on Omalizumab: A Comparative Analysis with Patients Who Switched to Other Biologics.

Hironobu Sunadome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.